BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $146,973 | -57.1% | 20,759 | -57.4% | 0.00% | -100.0% |
| Q2 2023 | $342,705 | -76.1% | 48,680 | -71.7% | 0.00% | -66.7% |
| Q1 2023 | $1,435,853 | -17.2% | 172,165 | +14.0% | 0.00% | -25.0% |
| Q4 2022 | $1,733,397 | +8.3% | 150,993 | +18.7% | 0.00% | 0.0% |
| Q3 2022 | $1,601,000 | -38.8% | 127,175 | -48.6% | 0.00% | -20.0% |
| Q2 2022 | $2,617,000 | +100.4% | 247,522 | +207.8% | 0.01% | +150.0% |
| Q1 2022 | $1,306,000 | +4564.3% | 80,426 | +3798.5% | 0.00% | – |
| Q4 2021 | $28,000 | -3.4% | 2,063 | 0.0% | 0.00% | – |
| Q3 2021 | $29,000 | -91.0% | 2,063 | -98.7% | 0.00% | -100.0% |
| Q1 2020 | $323,000 | -72.0% | 161,807 | -51.7% | 0.00% | -50.0% |
| Q4 2019 | $1,154,000 | +147.6% | 334,725 | +105.9% | 0.00% | +100.0% |
| Q3 2019 | $466,000 | +529.7% | 162,545 | +1115.5% | 0.00% | – |
| Q2 2017 | $74,000 | -82.3% | 13,373 | -73.1% | 0.00% | -100.0% |
| Q1 2017 | $417,000 | +301.0% | 49,638 | +206.4% | 0.00% | – |
| Q4 2016 | $104,000 | – | 16,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |